Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Archive of Events

<< 2014 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2016 >>

Finance and Value Creation Workshop

Start: Apr 8, 2015 9:00:00 AM
End: Apr 9, 2015 5:00:00 PM

Finance charts
What would a businessman (or woman) think if you asked "What is NPV?", or if you didn't understand how an organisation creates value for its investors?

Technology Strategy

Start: Apr 13, 2015 9:00:00 AM
End: Apr 13, 2015 5:00:00 PM

5-day CPD Accredited Technology Strategy Training for Small Businesses, Entrepreneurs, UCL Staff, Alumni and Post-graduate Students
<< 2014 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2016 >>